GRIFOLS, S.A. «...1112131415...» Page 14 out of 17 12/03/2021 08:27 GRIFOLS, S.A. Share buy-back , stabilisation and treasury stock programmes The Board of Directors of Grifols, S.A. has resolved to implement a buy-back programme of Grifols’ own shares. Register number: 7939 09/03/2021 08:33 GRIFOLS, S.A. On corporate transactions Grifols, S.A. informs that it has closed the transaction to acquire the remaining shares of GigaGen Inc. Register number: 7848 02/03/2021 19:49 GRIFOLS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2020 Register number: 7727 01/03/2021 08:34 GRIFOLS, S.A. On corporate transactions Grifols informs that it has closed the transaction to acquire 25 U.S. based plasma donation centers from BPL Plasma, Inc, a subsidiary of Bio Products Laboratory Holdings Limited Register number: 7653 26/02/2021 08:19 GRIFOLS, S.A. On business and financial situation Press release fiscal year 2020 results Register number: 7504 22/02/2021 08:44 GRIFOLS, S.A. On corporate governance The Board of Directors of Grifols, S.A. has resolved, in its meeting held on 19 February 2021 to approve, among other resolutions, the Regulations of the Sustainability Committee. Register number: 7185 22/02/2021 08:34 GRIFOLS, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2020 Register number: 7184 22/02/2021 08:32 GRIFOLS, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2020 Register number: 7183 18/02/2021 16:18 GRIFOLS, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 7162 19/01/2021 11:04 GRIFOLS, S.A. Other relevant information Grifols begins clinical trial of a new medicine that would provide immediate immunity against COVID-19. Register number: 6703 Page 14 out of 17 «...1112131415...»
